This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cardior Pharmaceuticals Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Wilfried Hauke - Innovator in Cardiac Treatment
Introduction
Wilfried Hauke is an inventor based in Wiesbaden, Germany. He is currently associated with Novo Nordisk A/S, where he contributes to advancements in medical science. Although he has not yet been granted any patents, his work focuses on innovative treatments for heart failure.
Latest Patent Applications
Wilfried Hauke's notable patent application is titled "Treatment of Heart Failure in Human Subjects." This invention refers to an oligonucleotide that effectively inhibits microRNA miR-132. It is aimed at its use in medicine, particularly in the prevention or treatment of cardiac and/or fibrotic disorders in human subjects.
Conclusion
Wilfried Hauke's contributions to the field of cardiac treatment highlight his commitment to medical innovation, even in the absence of granted patents. His work has the potential to significantly impact the treatment of heart-related disorders.